Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 5
Submit an article Journal homepage
919
Views
7
CrossRef citations to date
0
Altmetric
Letter

Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents

Anne-Marie RonchettiDepartment of Hematology, Assistance Publique-Hopitaux de Paris (AP-HP) Saint-Antoine, Université Pierre et Marie Curie, Paris, France
,
Françoise IsnardDepartment of Hematology, Assistance Publique-Hopitaux de Paris (AP-HP) Saint-Antoine, Université Pierre et Marie Curie, Paris, France
,
Marc BuffetDepartment of Hematology, Assistance Publique-Hopitaux de Paris (AP-HP) Saint-Antoine, Université Pierre et Marie Curie, Paris, France
,
Tereza ComanDepartment of Hematology, Assistance Publique-Hopitaux de Paris (AP-HP) Saint-Antoine, Université Pierre et Marie Curie, Paris, France
,
Norbert-Claude GorinDepartment of Hematology, Assistance Publique-Hopitaux de Paris (AP-HP) Saint-Antoine, Université Pierre et Marie Curie, Paris, France
,
Paul CoppoDepartment of Hematology, Assistance Publique-Hopitaux de Paris (AP-HP) Saint-Antoine, Université Pierre et Marie Curie, Paris, France
,
Laurent GarderetDepartment of Hematology, Assistance Publique-Hopitaux de Paris (AP-HP) Saint-Antoine, Université Pierre et Marie Curie, Paris, France
&
Sandra MalakDepartment of Hematology, Assistance Publique-Hopitaux de Paris (AP-HP) Saint-Antoine, Université Pierre et Marie Curie, Paris, FranceCorrespondence[email protected]
 show all
Pages 1117-1119 | Received 13 Jul 2012, Accepted 18 Sep 2012, Published online: 08 Mar 2013

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tony Huynh, Elise Corre, Marie-Paule Lemonnier, Rémy Duléry, Zora Marjanovic, Nabaz Jaff, Simona Lapusan, Mohamad Mohty, Laurent Garderet & Paul Coppo. (2021) Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory disease. Leukemia & Lymphoma 62:9, pages 2235-2241.
Read now

Articles from other publishers (6)

Margaret E. Stalker & Tomer M. Mark. (2022) Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging Therapies. Current Oncology 29:7, pages 4464-4477.
Crossref
Louise Ainley, Selina J. Chavda, Nicholas Counsell, Simon Cheesman, Fiona Newrick, Jackie Horder, Charalampia Kyriakou, Xenofon Papanikolaou, Jonathan Sive, Lydia Lee, Ashutosh Wechalekar, Atul Mehta, Rakesh Popat, Neil Rabin & Kwee Yong. (2020) DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation. British Journal of Haematology 192:3.
Crossref
Vidya Kollu, Rafiullah Khan & Umar Farooq. (2019) Leptotrichia Bacteremia After Chemotherapy for Hematologic Malignancy. American Journal of Therapeutics 26:6, pages e738-e740.
Crossref
Donald C. Moore, Justin R. Arnall & Dragos C. Plesca. (2018) Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting. American Journal of Health-System Pharmacy 75:22, pages 1824-1830.
Crossref
Rafiullah Khan, Sarah L. Mott, Allyson Schultz, Y. S. Jethava & Guido Tricot. (2018) Bloodless tandem autologous transplant in Jehovah’s Witness patients. Bone Marrow Transplantation 53:11, pages 1428-1433.
Crossref
Corey Toocheck & Daniel Pinkhas. (2018) Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy. BMJ Case Reports, pages bcr-2017-223611.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.